Literature DB >> 9419974

Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.

E Porfiri1, B Rubinfeld, I Albert, K Hovanes, M Waterman, P Polakis.   

Abstract

Signal transduction by beta-catenin involves its posttranslational stabilization and import to the nucleus where it interacts with transcription factors. Recent implications for beta-catenin signaling in cancer prompted us to examine colon cancer cell lines for the expression of LEF-1, a transcription factor that binds to beta-catenin. The analysis of several cell lines revealed the expression of LEF1 mRNA and a constitutive association of the LEF-1 protein with beta-catenin. In contrast to the colon cells, PC12 and 293 cells did not contain a beta-catenin-LEF-1 complex, even though both proteins were detected in cell lysates. In these cells, the association of endogenous LEF1 and beta-catenin was induced by stimulation with the wnt-1 proto-oncogene. The complex formed following transient stimulation with wnt-1 and also persisted in cells stably expressing wnt-1. Ectopic overexpression of beta-catenin in 293 cells also induced the assembly of the beta-catenin-LEF-1 complex and activated gene transcription from a LEF-1-dependent promotor. Expression of mutant oncogenic forms of beta-catenin identified in cancer cells resulted in higher levels of transcriptional activity. The results suggest that a cancer pathway driven by wnt-1, or mutant forms of beta-catenin, may involve the formation of a persistent transcriptionally active complex of beta-catenin and LEF1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9419974     DOI: 10.1038/sj.onc.1201462

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  52 in total

1.  The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates.

Authors:  A Hecht; K Vleminckx; M P Stemmler; F van Roy; R Kemler
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

2.  High glucose microenvironments inhibit the proliferation and migration of bone mesenchymal stem cells by activating GSK3β.

Authors:  Bo Zhang; Na Liu; Haigang Shi; Hao Wu; Yuxuan Gao; Huixia He; Bin Gu; Hongchen Liu
Journal:  J Bone Miner Metab       Date:  2015-04-04       Impact factor: 2.626

3.  Wnt activation and alternative promoter repression of LEF1 in colon cancer.

Authors:  Tony W-H Li; Ju-Hui T Ting; Noriko N Yokoyama; Alla Bernstein; Marc van de Wetering; Marian L Waterman
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 4.  Can we safely target the WNT pathway?

Authors:  Michael Kahn
Journal:  Nat Rev Drug Discov       Date:  2014-07       Impact factor: 84.694

5.  Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.

Authors:  B Mann; M Gelos; A Siedow; M L Hanski; A Gratchev; M Ilyas; W F Bodmer; M P Moyer; E O Riecken; H J Buhr; C Hanski
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

6.  Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.

Authors:  Kang Ho Kim; Ho Jun Seol; Eun Hee Kim; Jinguen Rheey; Hyun Jin Jin; Yeri Lee; Kyeung Min Joo; Jeongwu Lee; Do-Hyun Nam
Journal:  Neuro Oncol       Date:  2012-12-20       Impact factor: 12.300

7.  Protective versus promotional effects of white tea and caffeine on PhIP-induced tumorigenesis and beta-catenin expression in the rat.

Authors:  Rong Wang; W Mohaiza Dashwood; Christiane V Löhr; Kay A Fischer; Clifford B Pereira; Mandy Louderback; Hitoshi Nakagama; George S Bailey; David E Williams; Roderick H Dashwood
Journal:  Carcinogenesis       Date:  2008-02-17       Impact factor: 4.944

Review 8.  Beta-catenin versus the other armadillo catenins: assessing our current view of canonical Wnt signaling.

Authors:  Rachel K Miller; Ji Yeon Hong; William A Muñoz; Pierre D McCrea
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 9.  Animal models of colorectal cancer.

Authors:  Robert L Johnson; James C Fleet
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

10.  Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.

Authors:  Desheng Lu; Jerry X Liu; Tomoyuki Endo; Haowen Zhou; Shiyin Yao; Karl Willert; Ingo G H Schmidt-Wolf; Thomas J Kipps; Dennis A Carson
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.